We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > binx health

News List

binx health™ Submits Request for Emergency Use Authorization for First CRISPR-based Point-of-care Test for COVID-19 prnewswire
May 19, 2021
Platform poised to be first CLIA-waived CRISPR-based, point-of-care COVID-19 device with central-lab performance, developed in collaboration with Sherlock Biosciences
binx health receives EUA Authorizing at-Home COVID-19 Sample Collection by Universities, Employers americanpharmaceuticalreview
December 16, 2020
binx health has received an amendment to its COVID-19 Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), this time for centralized specimen collection kit distribution and retrieval by large partners.